Navigation Links
SeqWright's Partnership with EraGen Biosciences Contributes to FDA Market Clearance Success
Date:7/13/2010

HOUSTON, July 13 /PRNewswire/ -- EraGen Biosciences Inc., Madison, Wis., was congratulated today by SeqWright, Inc., Houston, on EraGen's successful FDA 510(k) market clearance of its MultiCode-RTx HSV 1 & 2 Kit.  This new kit is the first FDA-cleared PCR-based qualitative in vitro diagnostic test for the detection and typing of HSV-1 and HSV-2 from vaginal lesion swab specimens in symptomatic female patients.  The kit will be used as an aid in the diagnosis of genital herpes infection.  With SeqWright's significant contributions, EraGen said it was able to obtain the FDA clearance in record time.  

SeqWright is a GLP-compliant, CLIA-certified leader in the field of contract genomics and is proud to have provided the FDA-level Sanger Sequencing, HSV type calling and genotyping analysis, which validated EraGen's MultiCode-RTx HSV 1&2 Kit.  

About SeqWright

SeqWright Incorporated is a world-class genomic services support organization based in Houston, Texas with more than a decade of experience specializing in providing access to state-of- the-art molecular biology and genomic services in a highly regulated GLP/CLIA environment.  For additional information about SeqWright and its services, please visit www.seqwright.com.

About EraGen Biosciences

EraGen Biosciences develops, manufactures and markets innovative molecular diagnostic products that are driving a new era in clinical diagnostics and research. The company's in-market and pipeline products, based on its novel, patented MultiCode® platform chemistry, are the next generation of DNA- and RNA-based testing for the early detection of infectious diseases and genetic conditions. EraGen's expanding menu of high-quality, easy-to-use products position the company for leadership in molecular diagnostics. For more information, visit the EraGen website at www.eragen.com.


'/>"/>
SOURCE SeqWright, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Partnership for Quality Medical Donations Commits to Long-Term Recovery in Haiti
2. JDRF Reaches Milestone in Artificial Pancreas Project in Partnership with UC Santa Barbara and Sansum Diabetes Research Institute
3. Ethicon Endo-Surgery Extends Research Partnership with $13.5 Million Grant to University of Cincinnati
4. LifeNet Health and Salvin Dental Specialties Announce Partnership
5. Talecris Forms Partnership to Co-Promote Life-Saving Rabies Products
6. St. Jude Medical and iRhythm Technologies Enter into Partnership to Co-Market Novel Cardiac Rhythm Monitor
7. Swedish Cancer Institute and Elekta Launch Renewed Partnership Agreement to Continue the Flow of World-Class Technology, Services to Cancer Patients in the Pacific Northwest and Beyond
8. OrthoAccel Technologies, Inc. and AB Orthodontics Announce Partnership and Australian Product Introduction
9. Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services Utilizing the RDT 1000 for Sequence Enrichment and Targeted Resequencing Validation
10. SiteJabber & LegitScript Launch Partnership to Improve Transparency Around Online Pharmacies
11. GeneGo Releases Content and Tools From Industry-FDA Driven MetaTox Partnership Via ToxHunter(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July ... UTHR ) announced today that it will report ... opens on Thursday, July 27, 2017. ... on Thursday, July 27, 2017, at 9:00 a.m. Eastern ... international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference ...
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/15/2017)... Enterin Inc., a Philadelphia -based ... today announced the completion of a $12.7 million Series A ... as well as the participation of existing investors. ... the support of New Ventures III and our current investors, ... the potential of our platform technology to transform the course ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... MedMatchPlus+ has ... chances of acceptance to a residency in a United States hospital. Being accepted ... the U.S. , According to data released by the ECFMG®, every year, 50 ...
(Date:7/21/2017)... ... July 21, 2017 , ... Sharon ... the signature product of her research center at Bio-Logic Aqua Research® Water Life ... and the greatest number of sufferers of blindness. “We think that Nature’s Tears® ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the ... from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related ... though activity levels decline over time. The study, presented today at the ...
(Date:7/21/2017)... ONTARIO, CANADA (PRWEB) , ... July 21, 2017 ... ... give insight into why concussion rates are on the rise, say researchers presenting ... Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the patterns ...
(Date:7/20/2017)... ... 2017 , ... ChenMed , a leading provider of value-based care for ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family ... of Ambulatory Services for the UVA Health System, brings 30 years of highly relevant ...
Breaking Medicine News(10 mins):